Pfizer Wins China Business Confidentiality Infringement Lawsuit
This article was originally published in PharmAsia News
Executive Summary
Pfizer and Guangzhou Welman Pharmaceutical have been embroiled in a legal battle over Viagra's Chinese trademark Weige for 10 years (PharmAsia News, Apr. 14, 2008). In 2003, Pfizer hired Shanghai AIAL Information Consulting to investigate Guangzhou Welman Pharmaceutical and Shanghai Oriental Pharmaceutical, and submitted the report to the State Administration for Industry and Commerce. However, Welman considered some content in the report to infringe on its business confidentiality and sued Pfizer for unfair competition. After the trial, Guangzhou Intermediate People's Court delivered the judgment that the content of Pfizer's investigation did not constitute unfair competition, nor violate Welman's business confidentiality. (Click here for more - Chinese Language)
You may also be interested in...
Pfizer Loses Viagra Trademark Battle In China
Beijing Municipal Higher People's Court has rejected Pfizer's claims of trademark infringement and unfair competition against Guangzhou Welman Pharmaceutical and three other companies. The final verdict ended Pfizer's 10-year legal battle to secure the rights for Viagra's Chinese name "Weige" in China, trademarked by Welman in 1998. Welman says it has lost substantial marketshare in its erectile dysfunction drug over the past decade to counterfeit Viagra, which is the real rival. The firm does not dismiss the possibility of collaborating with Pfizer, including having joint use of the Weige trademark, to crack down on fake Viagra to reach a win-win situation. (Click here for more - Chinese Language)
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.